Further, we demonstrated that the expression of antiapoptotic factors, particularly those of Bcl-2 and survivin, changed significantly in relation to tumor grading, with higher expression levels of BCL-2 in low grade tumors and strongly prominent expression of survivin in high grade tumors [36]. This evidence concerns the gene BCL2 and neoplasm.